IOBTQ · IO Biotech, Inc.
$0.00
At close · Jul 27
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has concluded that the aforementioned conditions, among others, raise substantial doubt about the Company’s ability to continue as a going concern for one year after the date the financial statements are issued and therefore, the Company may not be able to continue its currently ongoing research and development activities as planned and realize its assets and satisfy its liabilities in the normal course of business.”View the 10-Q filed Nov 14, 2025
Market Cap
$71,948
Shares
71.95M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-09-11 | Novo Holdings A/S | Stockholder | 1,000,000 | 2024-09-11 | Morgan Stanley & Co. LLC |
| 2024-07-25 | Novo Holdings A/S | 10% Stockholder | 75,000 | 2024-07-25 | Morgan Stanley & Co. LLC |
| 2024-05-10 | Novo Holdings A/S | 10% Stockholder | 658,809 | 2024-05-10 | Morgan Stanley & Co. LLC |
| 2024-02-09 | Novo Holdings A/S | 10% Stockholder | 658,809 | 2024-02-09 | Morgan Stanley & Co. LLC |
Showing 1–4 of 4 filings